Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 109,749	$ 2,623
Accounts receivable, net	307,201	244,251
Fair value of derivatives	5,146	48,869
Prepaid expenses and other current assets	7,717	12,505
Total current assets	429,813	308,248
Properties and equipment, net	4,846,682	4,859,199
Fair value of derivatives	8,909	9,565
Other assets	48,585	60,961
Total Assets	5,333,989	5,237,973
Current liabilities:
Accounts payable	177,099	90,635
Production tax liability	75,719	124,475
Fair value of derivatives	393,180	98,152
Funds held for distribution	225,134	177,132
Accrued interest payable	15,354	14,734
Other accrued expenses	77,559	81,715
Current portion of long-term debt	197,919	193,014
Total current liabilities	1,161,964	779,857
Long-term debt	1,242,676	1,409,548
Asset retirement obligations	121,628	132,637
Fair value of derivatives	100,675	36,359
Other liabilities	242,140	264,034
Total liabilities	2,869,083	2,622,435
Stockholders' Equity:
Common shares - par value $0.01 per share, 150,000,000 authorized, 98,906,605 and 99,758,720 issued as of June 30, 2021 and December 31, 2020, respectively	989	998
Additional paid-in capital	3,333,168	3,387,754
Accumulated deficit	(868,338)	(772,265)
Treasury shares - at cost, 20,000 and 37,510 as of June 30, 2021 and December 31, 2020, respectively	(913)	(949)
Total stockholders’ equity	2,464,906	2,615,538
Total Liabilities and Stockholders’ Equity	$ 5,333,989	$ 5,237,973
Common stock, shares authorized	150,000,000	150,000,000